Gout
Conditions
Interventions
TCM Clinical Pathway Group:Comprehensive TCM Treatment
Not TCM Clinical Pathway Group: Non-traditional Chinese medicine clinical pathway treatment: colchicine and/or nonsteroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids etc.
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria are as follows: 1)Meet the Western medicine diagnostic criteria for gout; 2)Have a VAS score of 3=VAS<7 with the duration from gout onset to enrollment =1 week; 3)Meet the TCM diagnostic criteria for dampness-heat stagnation syndrome; 4)Be aged between 18 and 70; 5)Voluntarily participate in the study and sign the consent form.
Exclusion criteria
Exclusion criteria: The exclusion criteria are as follows: 1)Patients with secondary gout; 2)Those who have taken oral contraceptives or undergone hormone replacement therapy (with a prednisone dosage >10mg/d) within 3 months before the trial; 3)Patients with severe gastrointestinal diseases or ulcers; 4)Patients with severe dysfunction of important organs (heart brain liver kidney etc.) or malignant tumors; 5)Patients with mental illnesses long-term alcohol/drug abuse; 6)Pregnant or breastfeeding women; 7)Individuals with allergic constitutions or known allergies to components of the study drugs; 8)Those participating in other clinical trials that may affect the evaluation of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory markers:ESR CRP;Serum uric acid; | — |
Countries
China
Contacts
Public ContactSunlu
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed